| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |